Question

A 32-year-old male recovering from dengue fever initially showed clinical improvement but now presents with recurrence of high-grade fever, fatigue, and pancytopenia on day 10 of illness. He is hemodynamically stable with no bleeding manifestations. Which of the following investigations should be performed first to evaluate the cause of relapse and cytopenia?

• A. Serum ferritin
• B. Triglycerides
• C. Bone marrow study
• D. All of the above

Hint:

Maintain a high index of suspicion for secondary HLH in any patient with a recent viral infection, such as Dengue, Epstein-Barr Virus, or Cytomegalovirus, who unexpectedly develops unremitting fever, profound multilineage cytopenias, and hepatosplenomegaly.
Extreme elevations in serum ferritin levels, specifically those greater than 10,000 $\mu$g/L, are considered highly specific for HLH in the appropriate clinical setting and should prompt immediate further investigation.

Answer 1

The Correct Option is D

Concept:
A young adult patient exhibits a highly concerning biphasic clinical course, developing a sudden recurrence of high-grade fever and newly onset severe pancytopenia after an initial period of expected clinical recovery from Dengue fever.
This specific clinical trajectory and constellation of symptoms is highly suspicious for a post-infectious hyperinflammatory state, specifically secondary Hemophagocytic Lymphohistiocytosis (HLH), which is also frequently referred to as Macrophage Activation Syndrome (MAS) in certain rheumatological contexts.
Step-by-step Explanation:

• Dengue fever is an acute, mosquito-borne viral infection that typically runs a self-limited course, generally resolving within a week with appropriate supportive care.

• However, severe and potentially fatal immune-mediated complications can occasionally arise during the convalescent phase of the illness, triggered by an aberrant and uncontrolled host immune response.

• The sudden reappearance of unremitting high-grade fever, profound systemic fatigue, and multilineage blood count depression (pancytopenia) after an initial phase of clinical improvement is a classic and urgent red flag for secondary Hemophagocytic Lymphohistiocytosis (HLH).

• Secondary HLH is a life-threatening syndrome characterized by the uncontrolled, pathological activation of macrophages and CD8+ T-lymphocytes, leading to a massive, systemic cytokine storm and extensive collateral tissue damage.

• The definitive diagnosis of HLH relies heavily on meeting the established HLH-2004 diagnostic criteria, which strictly requires the patient to fulfill at least five out of eight specific clinical and laboratory findings.

• These diagnostic criteria include: prolonged fever, splenomegaly, cytopenias affecting at least two out of three peripheral blood lineages, hypertriglyceridemia ($\ge$ 265 mg/dL) and/or hypofibrinogenemia, histological evidence of hemophagocytosis in the bone marrow, spleen, or lymph nodes, low or completely absent Natural Killer (NK) cell activity, markedly elevated serum ferritin levels ($\ge$ 500 $\mu$g/L), and elevated soluble CD25 (soluble IL-2 receptor) levels.

• Measuring serum ferritin (Option A) is a crucial initial step because ferritin levels are typically markedly and disproportionately elevated in HLH, often exceeding 10,000 $\mu$g/L, which helps significantly in gauging the severity of the systemic inflammatory activity.

• Evaluating serum triglycerides (Option B) is also essential because hypertriglyceridemia directly reflects the severe systemic inflammatory response and the resulting hepatic dysfunction characteristically seen in the cytokine storm of HLH.

• Performing a bone marrow study (Option C) is absolutely critical to visually demonstrate active hemophagocytosis, which is the pathological process of activated macrophages engulfing normal red blood cells, leukocytes, and platelets, and to simultaneously rule out occult hematological malignancies that could present similarly.

• Because all of these listed laboratory and pathological parameters are integral and mandatory components of the HLH-2004 diagnostic criteria, a comprehensive and urgent initial workup must logically include all of them simultaneously to rapidly confirm the diagnosis and initiate life-saving immunosuppressive therapy.
Final Answer:
To promptly evaluate and confirm a highly suspected case of secondary HLH, serum ferritin, fasting triglycerides, and a bone marrow study must all be performed together as part of the primary diagnostic workup.